RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Guangdi Wang to Carcinoma, Hepatocellular

Back to Details
This is a "connection" page, showing publications Guangdi Wang has written about Carcinoma, Hepatocellular.
Guangdi Wang
Connection Strength
0.026
Carcinoma, Hepatocellular
  1. Li Y, Cao TT, Guo S, Zhong Q, Li CH, Li Y, Dong L, Zheng S, Wang G, Yin SF. Discovery of Novel Allopurinol Derivatives with Anticancer Activity and Attenuated Xanthine Oxidase Inhibition. Molecules. 2016 Jun 20; 21(6).
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support